DyeVert™ PLUS EZ:
Proven Contrast Reduction with Uncompromised Imaging
DyeVert™ PLUS:
Proven Contrast Reduction with Uncompromised Imaging
DyeVert™ PLUS EZ Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
Moderate and severe chronic kidney disease
Diabetes
Older age
Heart failure
Dye reduction
DyeVert™ PLUS EZ is the only FDA cleared product with the claim of reduced dye delivery to the patient without impacting image quality.
Proven results
DyeVert™ PLUS EZ clinical results show over 40% average reduction in contrast dosage injected to the patient.1
Real-time dose monitoring
DyeVert™ PLUS EZ module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.
1 Desch, S. et all. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J Cardiol (2018) https://doi.org/10.1016/j.ijcard.2017.12.107
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS EZ reduces contrast amount without compromising image quality. See for yourself.
Without contrast reduction
With DyeVert™ PLUS EZ contrast reduction
Real-Time Monitoring
Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert™ PLUS EZ technology.
The DyeVert™ PLUS EZ Technology
DyeVert™ PLUS EZ contrast reduction system is easy to use and incorporate into common cath-lab procedures.